Skip to content

Nuvalent, Inc. NUVL Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Pfizer logo
PfizerPFE
$14.2B+6.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$472K+27.6%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$1.8M+5.3%
Exelixis logo
ExelixisEXEL
$117.33M-2.2%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$6.88M+66.2%
Incyte logo
IncyteINCY
$126.59M-27.9%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s other non-current liabilities?
Nuvalent, Inc. (NUVL) reported other non-current liabilities of $0 in Q1 2026.
How has Nuvalent, Inc.'s other non-current liabilities changed year-over-year?
Nuvalent, Inc.'s other non-current liabilities decreased by 100.0% year-over-year, from $345K to $0.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.